APO Research
Talk to an analyst

APO RESEARCH · REPORT

Binge Eating Disorder Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Binge Eating Disorder Drug Market Analysis and Forecast 2026-2032

20 December 2025191 pages

Choose your research edition.

Industry ResearchBinge Eating Disorder Drug Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Binge Eating Disorder Drug Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Binge Eating Disorder Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Binge Eating Disorder Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Binge Eating Disorder Drug Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Binge Eating Disorder Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Binge Eating Disorder Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Binge Eating Disorder Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Binge Eating Disorder Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Binge Eating Disorder Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Binge Eating Disorder Drug include Novo Nordisk, Roche, Sunovion Pharmaceuticals, Opiant Pharmaceuticals, Omeros Corp, Heptares and Chronos Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Binge Eating Disorder Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Binge Eating Disorder Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Binge Eating Disorder Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Binge Eating Disorder Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Binge Eating Disorder Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Binge Eating Disorder Drug sales, projected growth trends, production technology, application and end-user industry.

Binge Eating Disorder Drug Segment by Company

Novo Nordisk

Roche

Sunovion Pharmaceuticals

Opiant Pharmaceuticals

Omeros Corp

Heptares

Chronos Therapeutics

Binge Eating Disorder Drug Segment by Type

Anti-obesity Medications

Anticonvulsants

Antidepressants

Binge Eating Disorder Drug Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Binge Eating Disorder Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Binge Eating Disorder Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Binge Eating Disorder Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Binge Eating Disorder Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Binge Eating Disorder Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Binge Eating Disorder Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Binge Eating Disorder Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Binge Eating Disorder Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Anti-obesity Medications Major Manufacturers Table 3. Anticonvulsants Major Manufacturers Table 4. Antidepressants Major Manufacturers Table 5. Global Binge Eating Disorder Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Retail Pharmacies Major Manufacturers Table 7. Online Pharmacies Major Manufacturers Table 8. Hospital Pharmacies Major Manufacturers Table 9. Binge Eating Disorder Drug Industry Trends Table 10. Binge Eating Disorder Drug Industry Drivers Table 11. Binge Eating Disorder Drug Industry Opportunities and Challenges Table 12. Binge Eating Disorder Drug Industry Restraints Table 13. Global Binge Eating Disorder Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Binge Eating Disorder Drug Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Binge Eating Disorder Drug Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Binge Eating Disorder Drug Revenue Market Share by Region (2021-2026) Table 17. Global Binge Eating Disorder Drug Revenue Market Share by Region (2027-2032) Table 18. Global Binge Eating Disorder Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Binge Eating Disorder Drug Sales by Region (2021-2026) & (K Units) Table 20. Global Binge Eating Disorder Drug Sales by Region (2027-2032) & (K Units) Table 21. Global Binge Eating Disorder Drug Sales Market Share by Region (2021-2026) Table 22. Global Binge Eating Disorder Drug Sales Market Share by Region (2027-2032) Table 23. Global Binge Eating Disorder Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Binge Eating Disorder Drug Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Binge Eating Disorder Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Binge Eating Disorder Drug Sales Market Share by Manufacturers (2021-2026) Table 27. Global Binge Eating Disorder Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Binge Eating Disorder Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Binge Eating Disorder Drug Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Binge Eating Disorder Drug Manufacturers, Product Type & Application Table 31. Global Binge Eating Disorder Drug Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Binge Eating Disorder Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Binge Eating Disorder Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Binge Eating Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Binge Eating Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Binge Eating Disorder Drug Revenue Market Share by Type (2021-2026) Table 38. Global Binge Eating Disorder Drug Revenue Market Share by Type (2027-2032) Table 39. Global Binge Eating Disorder Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Binge Eating Disorder Drug Sales by Type (2021-2026) & (K Units) Table 41. Global Binge Eating Disorder Drug Sales by Type (2027-2032) & (K Units) Table 42. Global Binge Eating Disorder Drug Sales Market Share by Type (2021-2026) Table 43. Global Binge Eating Disorder Drug Sales Market Share by Type (2027-2032) Table 44. Global Binge Eating Disorder Drug Price by Type (2021-2026) & (US$/Unit) Table 45. Global Binge Eating Disorder Drug Price by Type (2027-2032) & (US$/Unit) Table 46. Global Binge Eating Disorder Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Binge Eating Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Binge Eating Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Binge Eating Disorder Drug Revenue Market Share by Application (2021-2026) Table 50. Global Binge Eating Disorder Drug Revenue Market Share by Application (2027-2032) Table 51. Global Binge Eating Disorder Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Binge Eating Disorder Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Binge Eating Disorder Drug Sales by Application (2027-2032) & (K Units) Table 54. Global Binge Eating Disorder Drug Sales Market Share by Application (2021-2026) Table 55. Global Binge Eating Disorder Drug Sales Market Share by Application (2027-2032) Table 56. Global Binge Eating Disorder Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Binge Eating Disorder Drug Price by Application (2027-2032) & (US$/Unit) Table 58. Novo Nordisk Company Information Table 59. Novo Nordisk Business Overview Table 60. Novo Nordisk Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Novo Nordisk Binge Eating Disorder Drug Product Portfolio Table 62. Novo Nordisk Recent Development Table 63. Roche Company Information Table 64. Roche Business Overview Table 65. Roche Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Roche Binge Eating Disorder Drug Product Portfolio Table 67. Roche Recent Development Table 68. Sunovion Pharmaceuticals Company Information Table 69. Sunovion Pharmaceuticals Business Overview Table 70. Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Sunovion Pharmaceuticals Binge Eating Disorder Drug Product Portfolio Table 72. Sunovion Pharmaceuticals Recent Development Table 73. Opiant Pharmaceuticals Company Information Table 74. Opiant Pharmaceuticals Business Overview Table 75. Opiant Pharmaceuticals Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Opiant Pharmaceuticals Binge Eating Disorder Drug Product Portfolio Table 77. Opiant Pharmaceuticals Recent Development Table 78. Omeros Corp Company Information Table 79. Omeros Corp Business Overview Table 80. Omeros Corp Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Omeros Corp Binge Eating Disorder Drug Product Portfolio Table 82. Omeros Corp Recent Development Table 83. Heptares Company Information Table 84. Heptares Business Overview Table 85. Heptares Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Heptares Binge Eating Disorder Drug Product Portfolio Table 87. Heptares Recent Development Table 88. Chronos Therapeutics Company Information Table 89. Chronos Therapeutics Business Overview Table 90. Chronos Therapeutics Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Chronos Therapeutics Binge Eating Disorder Drug Product Portfolio Table 92. Chronos Therapeutics Recent Development Table 93. North America Binge Eating Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Binge Eating Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Binge Eating Disorder Drug Sales by Type (2021-2026) & (K Units) Table 96. North America Binge Eating Disorder Drug Sales by Type (2027-2032) & (K Units) Table 97. North America Binge Eating Disorder Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 98. North America Binge Eating Disorder Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 99. North America Binge Eating Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Binge Eating Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Binge Eating Disorder Drug Sales by Application (2021-2026) & (K Units) Table 102. North America Binge Eating Disorder Drug Sales by Application (2027-2032) & (K Units) Table 103. North America Binge Eating Disorder Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 104. North America Binge Eating Disorder Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 105. North America Binge Eating Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Binge Eating Disorder Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. North America Binge Eating Disorder Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. North America Binge Eating Disorder Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 109. North America Binge Eating Disorder Drug Sales by Country (2021-2026) & (K Units) Table 110. North America Binge Eating Disorder Drug Sales by Country (2027-2032) & (K Units) Table 111. North America Binge Eating Disorder Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 112. North America Binge Eating Disorder Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 113. United States Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 114. Canada Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 115. Europe Binge Eating Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Binge Eating Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Binge Eating Disorder Drug Sales by Type (2021-2026) & (K Units) Table 118. Europe Binge Eating Disorder Drug Sales by Type (2027-2032) & (K Units) Table 119. Europe Binge Eating Disorder Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 120. Europe Binge Eating Disorder Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 121. Europe Binge Eating Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Binge Eating Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Binge Eating Disorder Drug Sales by Application (2021-2026) & (K Units) Table 124. Europe Binge Eating Disorder Drug Sales by Application (2027-2032) & (K Units) Table 125. Europe Binge Eating Disorder Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 126. Europe Binge Eating Disorder Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 127. Europe Binge Eating Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Binge Eating Disorder Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. Europe Binge Eating Disorder Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. Europe Binge Eating Disorder Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 131. Europe Binge Eating Disorder Drug Sales by Country (2021-2026) & (K Units) Table 132. Europe Binge Eating Disorder Drug Sales by Country (2027-2032) & (K Units) Table 133. Europe Binge Eating Disorder Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 134. Europe Binge Eating Disorder Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 135. Germany Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 136. France Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 137. U.K. Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 138. Italy Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 139. Netherlands Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 140. Nordic Countries Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 141. China Binge Eating Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 142. China Binge Eating Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 143. China Binge Eating Disorder Drug Sales by Type (2021-2026) & (K Units) Table 144. China Binge Eating Disorder Drug Sales by Type (2027-2032) & (K Units) Table 145. China Binge Eating Disorder Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 146. China Binge Eating Disorder Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 147. China Binge Eating Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 148. China Binge Eating Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 149. China Binge Eating Disorder Drug Sales by Application (2021-2026) & (K Units) Table 150. China Binge Eating Disorder Drug Sales by Application (2027-2032) & (K Units) Table 151. China Binge Eating Disorder Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 152. China Binge Eating Disorder Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 153. Asia Binge Eating Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 154. Asia Binge Eating Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 155. Asia Binge Eating Disorder Drug Sales by Type (2021-2026) & (K Units) Table 156. Asia Binge Eating Disorder Drug Sales by Type (2027-2032) & (K Units) Table 157. Asia Binge Eating Disorder Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 158. Asia Binge Eating Disorder Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 159. Asia Binge Eating Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 160. Asia Binge Eating Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 161. Asia Binge Eating Disorder Drug Sales by Application (2021-2026) & (K Units) Table 162. Asia Binge Eating Disorder Drug Sales by Application (2027-2032) & (K Units) Table 163. Asia Binge Eating Disorder Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 164. Asia Binge Eating Disorder Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 165. Asia Binge Eating Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Asia Binge Eating Disorder Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. Asia Binge Eating Disorder Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. Asia Binge Eating Disorder Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 169. Asia Binge Eating Disorder Drug Sales by Country (2021-2026) & (K Units) Table 170. Asia Binge Eating Disorder Drug Sales by Country (2027-2032) & (K Units) Table 171. Asia Binge Eating Disorder Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 172. Asia Binge Eating Disorder Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 173. Japan Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 174. South Korea Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 175. India Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 176. Australia Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 177. China Taiwan Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 178. Southeast Asia Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 179. SAMEA Binge Eating Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 180. SAMEA Binge Eating Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 181. SAMEA Binge Eating Disorder Drug Sales by Type (2021-2026) & (K Units) Table 182. SAMEA Binge Eating Disorder Drug Sales by Type (2027-2032) & (K Units) Table 183. SAMEA Binge Eating Disorder Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 184. SAMEA Binge Eating Disorder Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 185. SAMEA Binge Eating Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 186. SAMEA Binge Eating Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 187. SAMEA Binge Eating Disorder Drug Sales by Application (2021-2026) & (K Units) Table 188. SAMEA Binge Eating Disorder Drug Sales by Application (2027-2032) & (K Units) Table 189. SAMEA Binge Eating Disorder Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 190. SAMEA Binge Eating Disorder Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 191. SAMEA Binge Eating Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. SAMEA Binge Eating Disorder Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. SAMEA Binge Eating Disorder Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. SAMEA Binge Eating Disorder Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 195. SAMEA Binge Eating Disorder Drug Sales by Country (2021-2026) & (K Units) Table 196. SAMEA Binge Eating Disorder Drug Sales by Country (2027-2032) & (K Units) Table 197. SAMEA Binge Eating Disorder Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 198. SAMEA Binge Eating Disorder Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 199. Brazil Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 200. Argentina Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 201. Chile Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 202. Colombia Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 203. Peru Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 204. Saudi Arabia Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 205. Israel Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 206. UAE Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 207. Turkey Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 208. Iran Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 209. Egypt Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Table 210. Key Raw Materials Table 211. Raw Materials Key Suppliers Table 212. Binge Eating Disorder Drug Distributors List Table 213. Binge Eating Disorder Drug Customers List Table 214. Research Programs/Design for This Report Table 215. Authors List of This Report Table 216. Secondary Sources Table 217. Primary Sources List of Figures Figure 1. Binge Eating Disorder Drug Image Figure 2. Global Binge Eating Disorder Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Binge Eating Disorder Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Anti-obesity Medications Image Figure 5. Anticonvulsants Image Figure 6. Antidepressants Image Figure 7. Global Binge Eating Disorder Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Binge Eating Disorder Drug Market Size Share 2021 VS 2025 VS 2032 Figure 9. Retail Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Hospital Pharmacies Image Figure 12. Global Binge Eating Disorder Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Binge Eating Disorder Drug Revenue (2021-2032) & (US$ Million) Figure 14. Global Binge Eating Disorder Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Binge Eating Disorder Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Binge Eating Disorder Drug Revenue Market Share by Region (2021-2032) Figure 17. Global Binge Eating Disorder Drug Sales (2021-2032) & (K Units) Figure 18. Global Binge Eating Disorder Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Binge Eating Disorder Drug Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Binge Eating Disorder Drug Sales YoY (2021-2032) & (K Units) Figure 21. Europe Binge Eating Disorder Drug Sales YoY (2021-2032) & (K Units) Figure 22. China Binge Eating Disorder Drug Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Binge Eating Disorder Drug Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Binge Eating Disorder Drug Sales YoY (2021-2032) & (K Units) Figure 25. Global Binge Eating Disorder Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Binge Eating Disorder Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Binge Eating Disorder Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Binge Eating Disorder Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Binge Eating Disorder Drug Revenue Market Share by Type (2021-2032) Figure 31. Global Binge Eating Disorder Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Binge Eating Disorder Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Binge Eating Disorder Drug Sales Market Share by Type (2021-2032) Figure 34. Global Binge Eating Disorder Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Binge Eating Disorder Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Binge Eating Disorder Drug Revenue Market Share by Application (2021-2032) Figure 37. Global Binge Eating Disorder Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Binge Eating Disorder Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Binge Eating Disorder Drug Sales Market Share by Application (2021-2032) Figure 40. North America Binge Eating Disorder Drug Revenue Share by Type (2021-2032) Figure 41. North America Binge Eating Disorder Drug Sales Share by Type (2021-2032) Figure 42. North America Binge Eating Disorder Drug Revenue Share by Application (2021-2032) Figure 43. North America Binge Eating Disorder Drug Sales Share by Application (2021-2032) Figure 44. North America Binge Eating Disorder Drug Revenue Share by Country (2021-2032) Figure 45. North America Binge Eating Disorder Drug Sales Share by Country (2021-2032) Figure 46. Europe Binge Eating Disorder Drug Revenue Share by Type (2021-2032) Figure 47. Europe Binge Eating Disorder Drug Sales Share by Type (2021-2032) Figure 48. Europe Binge Eating Disorder Drug Revenue Share by Application (2021-2032) Figure 49. Europe Binge Eating Disorder Drug Sales Share by Application (2021-2032) Figure 50. Europe Binge Eating Disorder Drug Revenue Share by Country (2021-2032) Figure 51. Europe Binge Eating Disorder Drug Sales Share by Country (2021-2032) Figure 52. China Binge Eating Disorder Drug Revenue Share by Type (2021-2032) Figure 53. China Binge Eating Disorder Drug Sales Share by Type (2021-2032) Figure 54. China Binge Eating Disorder Drug Revenue Share by Application (2021-2032) Figure 55. China Binge Eating Disorder Drug Sales Share by Application (2021-2032) Figure 56. Asia Binge Eating Disorder Drug Revenue Share by Type (2021-2032) Figure 57. Asia Binge Eating Disorder Drug Sales Share by Type (2021-2032) Figure 58. Asia Binge Eating Disorder Drug Revenue Share by Application (2021-2032) Figure 59. Asia Binge Eating Disorder Drug Sales Share by Application (2021-2032) Figure 60. Asia Binge Eating Disorder Drug Revenue Share by Country (2021-2032) Figure 61. Asia Binge Eating Disorder Drug Sales Share by Country (2021-2032) Figure 62. SAMEA Binge Eating Disorder Drug Revenue Share by Type (2021-2032) Figure 63. SAMEA Binge Eating Disorder Drug Sales Share by Type (2021-2032) Figure 64. SAMEA Binge Eating Disorder Drug Revenue Share by Application (2021-2032) Figure 65. SAMEA Binge Eating Disorder Drug Sales Share by Application (2021-2032) Figure 66. SAMEA Binge Eating Disorder Drug Revenue Share by Country (2021-2032) Figure 67. SAMEA Binge Eating Disorder Drug Sales Share by Country (2021-2032) Figure 68. Binge Eating Disorder Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Binge Eating Disorder Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-obesity Medications
  • Anticonvulsants
  • Antidepressants
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Novo Nordisk
  • Roche
  • Sunovion Pharmaceuticals
  • Opiant Pharmaceuticals
  • Omeros Corp
  • Heptares
  • Chronos Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Binge Eating Disorder Drug Market by Type
  3. 1.2.1 Global Binge Eating Disorder Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Anti-obesity Medications
  5. 1.2.3 Anticonvulsants
  6. 1.2.4 Antidepressants
  7. 1.3 Binge Eating Disorder Drug Market by Application
  8. 1.3.1 Global Binge Eating Disorder Drug Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Retail Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Hospital Pharmacies
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Binge Eating Disorder Drug Market Dynamics
  1. 2.1 Binge Eating Disorder Drug Industry Trends
  2. 2.2 Binge Eating Disorder Drug Industry Drivers
  3. 2.3 Binge Eating Disorder Drug Industry Opportunities and Challenges
  4. 2.4 Binge Eating Disorder Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Binge Eating Disorder Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Binge Eating Disorder Drug Revenue by Region
  3. 3.2.1 Global Binge Eating Disorder Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Binge Eating Disorder Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Binge Eating Disorder Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Binge Eating Disorder Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Binge Eating Disorder Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Binge Eating Disorder Drug Sales by Region
  9. 3.4.1 Global Binge Eating Disorder Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Binge Eating Disorder Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Binge Eating Disorder Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Binge Eating Disorder Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Binge Eating Disorder Drug Revenue by Manufacturers
  2. 4.1.1 Global Binge Eating Disorder Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Binge Eating Disorder Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Binge Eating Disorder Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Binge Eating Disorder Drug Sales by Manufacturers
  6. 4.2.1 Global Binge Eating Disorder Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Binge Eating Disorder Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Binge Eating Disorder Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Binge Eating Disorder Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Binge Eating Disorder Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Binge Eating Disorder Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Binge Eating Disorder Drug Manufacturers, Product Type & Application
  13. 4.7 Global Binge Eating Disorder Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Binge Eating Disorder Drug Market CR5 and HHI
  16. 4.8.2 2025 Binge Eating Disorder Drug Tier 1, Tier 2, and Tier 3
5 Binge Eating Disorder Drug Market by Type
  1. 5.1 Global Binge Eating Disorder Drug Revenue by Type
  2. 5.1.1 Global Binge Eating Disorder Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Binge Eating Disorder Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Binge Eating Disorder Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Binge Eating Disorder Drug Sales by Type
  6. 5.2.1 Global Binge Eating Disorder Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Binge Eating Disorder Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Binge Eating Disorder Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Binge Eating Disorder Drug Price by Type
6 Binge Eating Disorder Drug Market by Application
  1. 6.1 Global Binge Eating Disorder Drug Revenue by Application
  2. 6.1.1 Global Binge Eating Disorder Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Binge Eating Disorder Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Binge Eating Disorder Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Binge Eating Disorder Drug Sales by Application
  6. 6.2.1 Global Binge Eating Disorder Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Binge Eating Disorder Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Binge Eating Disorder Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Binge Eating Disorder Drug Price by Application
7 Company Profiles
  1. 7.1 Novo Nordisk
  2. 7.1.1 Novo Nordisk Company Information
  3. 7.1.2 Novo Nordisk Business Overview
  4. 7.1.3 Novo Nordisk Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novo Nordisk Binge Eating Disorder Drug Product Portfolio
  6. 7.1.5 Novo Nordisk Recent Developments
  7. 7.2 Roche
  8. 7.2.1 Roche Company Information
  9. 7.2.2 Roche Business Overview
  10. 7.2.3 Roche Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Roche Binge Eating Disorder Drug Product Portfolio
  12. 7.2.5 Roche Recent Developments
  13. 7.3 Sunovion Pharmaceuticals
  14. 7.3.1 Sunovion Pharmaceuticals Company Information
  15. 7.3.2 Sunovion Pharmaceuticals Business Overview
  16. 7.3.3 Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sunovion Pharmaceuticals Binge Eating Disorder Drug Product Portfolio
  18. 7.3.5 Sunovion Pharmaceuticals Recent Developments
  19. 7.4 Opiant Pharmaceuticals
  20. 7.4.1 Opiant Pharmaceuticals Company Information
  21. 7.4.2 Opiant Pharmaceuticals Business Overview
  22. 7.4.3 Opiant Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Opiant Pharmaceuticals Binge Eating Disorder Drug Product Portfolio
  24. 7.4.5 Opiant Pharmaceuticals Recent Developments
  25. 7.5 Omeros Corp
  26. 7.5.1 Omeros Corp Company Information
  27. 7.5.2 Omeros Corp Business Overview
  28. 7.5.3 Omeros Corp Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Omeros Corp Binge Eating Disorder Drug Product Portfolio
  30. 7.5.5 Omeros Corp Recent Developments
  31. 7.6 Heptares
  32. 7.6.1 Heptares Company Information
  33. 7.6.2 Heptares Business Overview
  34. 7.6.3 Heptares Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Heptares Binge Eating Disorder Drug Product Portfolio
  36. 7.6.5 Heptares Recent Developments
  37. 7.7 Chronos Therapeutics
  38. 7.7.1 Chronos Therapeutics Company Information
  39. 7.7.2 Chronos Therapeutics Business Overview
  40. 7.7.3 Chronos Therapeutics Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Chronos Therapeutics Binge Eating Disorder Drug Product Portfolio
  42. 7.7.5 Chronos Therapeutics Recent Developments
8 North America
  1. 8.1 North America Binge Eating Disorder Drug Market Size by Type
  2. 8.1.1 North America Binge Eating Disorder Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Binge Eating Disorder Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Binge Eating Disorder Drug Price by Type (2021-2032)
  5. 8.2 North America Binge Eating Disorder Drug Market Size by Application
  6. 8.2.1 North America Binge Eating Disorder Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Binge Eating Disorder Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Binge Eating Disorder Drug Price by Application (2021-2032)
  9. 8.3 North America Binge Eating Disorder Drug Market Size by Country
  10. 8.3.1 North America Binge Eating Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Binge Eating Disorder Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Binge Eating Disorder Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Binge Eating Disorder Drug Market Size by Type
  2. 9.1.1 Europe Binge Eating Disorder Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Binge Eating Disorder Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Binge Eating Disorder Drug Price by Type (2021-2032)
  5. 9.2 Europe Binge Eating Disorder Drug Market Size by Application
  6. 9.2.1 Europe Binge Eating Disorder Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Binge Eating Disorder Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Binge Eating Disorder Drug Price by Application (2021-2032)
  9. 9.3 Europe Binge Eating Disorder Drug Market Size by Country
  10. 9.3.1 Europe Binge Eating Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Binge Eating Disorder Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Binge Eating Disorder Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Binge Eating Disorder Drug Market Size by Type
  2. 10.1.1 China Binge Eating Disorder Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Binge Eating Disorder Drug Sales by Type (2021-2032)
  4. 10.1.3 China Binge Eating Disorder Drug Price by Type (2021-2032)
  5. 10.2 China Binge Eating Disorder Drug Market Size by Application
  6. 10.2.1 China Binge Eating Disorder Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Binge Eating Disorder Drug Sales by Application (2021-2032)
  8. 10.2.3 China Binge Eating Disorder Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Binge Eating Disorder Drug Market Size by Type
  2. 11.1.1 Asia Binge Eating Disorder Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Binge Eating Disorder Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Binge Eating Disorder Drug Price by Type (2021-2032)
  5. 11.2 Asia Binge Eating Disorder Drug Market Size by Application
  6. 11.2.1 Asia Binge Eating Disorder Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Binge Eating Disorder Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Binge Eating Disorder Drug Price by Application (2021-2032)
  9. 11.3 Asia Binge Eating Disorder Drug Market Size by Country
  10. 11.3.1 Asia Binge Eating Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Binge Eating Disorder Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Binge Eating Disorder Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Binge Eating Disorder Drug Market Size by Type
  2. 12.1.1 SAMEA Binge Eating Disorder Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Binge Eating Disorder Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Binge Eating Disorder Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Binge Eating Disorder Drug Market Size by Application
  6. 12.2.1 SAMEA Binge Eating Disorder Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Binge Eating Disorder Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Binge Eating Disorder Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Binge Eating Disorder Drug Market Size by Country
  10. 12.3.1 SAMEA Binge Eating Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Binge Eating Disorder Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Binge Eating Disorder Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Binge Eating Disorder Drug Value Chain Analysis
  2. 13.1.1 Binge Eating Disorder Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Binge Eating Disorder Drug Production Mode & Process
  6. 13.2 Binge Eating Disorder Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Binge Eating Disorder Drug Distributors
  9. 13.2.3 Binge Eating Disorder Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst